Status:

RECRUITING

A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis

Lead Sponsor:

Amgen

Conditions:

Behçet's Disease

Juvenile Psoriatic Arthritis

Eligibility:

All Genders

5-18 years

Phase:

PHASE3

Brief Summary

The primary objective of this study is to evaluate the long-term safety of apremilast in subjects 2 years of age or older with oral ulcers associated with Behçets disease or 5 years of age or older wi...

Eligibility Criteria

Inclusion Criteria:

  • Informed consent / assent obtained
  • Must have completed Week 52 on treatment on core study and must be < 18 years of age at the time the informed consent document is signed
  • Age and sex specific body mass index (BMI) no lower in range than the 5th percentile on Centers for Disease Control (CDC growth chart) at enrollment
  • Willing to adhere to study visit schedule and protocol requirements
  • Must have acceptable benefit/risk for continued treatment with apremilast

Exclusion Criteria:

  • Answer "yes" to any question on C-SSRS at Week 52 visit of core study
  • Scheduled surgery or other interventions that would interrupt study participation
  • Female participants of childbearing potential unwilling to use protocol specified method of contraception during treatment and for 30 days after last dose
  • Female participants planning to become pregnant while on study through 30 days after last dose
  • Female participants of childbearing potential with positive pregnancy test at Week 0
  • Known sensitivity to any products to be administered during dosing

Key Trial Info

Start Date :

March 23 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 17 2036

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT05767047

Start Date

March 23 2023

End Date

March 17 2036

Last Update

December 1 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

General Hospital of Thessaloniki Ippokrateio

Thessaloniki, Greece, 54642

2

Meir Medical Center

Kfar Saba, Israel, 4428164

3

Hospital Universitari i Politecnic La Fe

Valencia, Valencia, Spain, 46026

4

Hospital Universitario Ramon y Cajal

Madrid, Spain, 28034

A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis | DecenTrialz